NASDAQ · OPHTHALMIC GOODS · LARGE CAP
The Cooper Companies, Inc. COO
18 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$4.1B
▲ 5.1% vs FY2024
EPS · FY25
$1.87
Dividend / sh · FY25
—
Payout · FY25
0%
ROE · FY25
4.6%
Net margin · FY25
9.2%
Dividend coverage
148.0×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 4.1B
Revenue, FY2025 · full 18-year series below
Revenue
Net income
9 cents of every revenue dollar became profit this year.
Per share
USD 1.87
Diluted EPS, FY2025
EPS
Dividend
Earnings covered the dividend 148.0 times — the rest stayed in the company.
Profitability
4.6%
Return on equity, FY2025
ROE
Operating margin16.7%
Net margin9.2%
Return on assets3.0%
Each USD of equity produced 5 cents of profit this year.
Returned to shareholders
USD 290.1M
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 290.1M
Share of profit77.4%
Consecutive raises—
USD 290.1M in buybacks — 77% of the year's profit went back to shareholders.
Growth
+11.0% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+7.3%
+11.0%
+8.6%
+8.8%
Net income
−1.0%
+9.5%
+6.3%
+8.3%
Returned to shareholders
+52.7%
+41.7%
+15.2%
+36.5%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.20B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 12.4B
total assets, end of FY2025
Total assetsUSD 12.4B
EquityUSD 8.2B
CashUSD 110.6M
Gross debtUSD 2.5B
Net debtUSD 2.4B
Current ratio1.89×
Net debt stands at 29% of equity.
History
18 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Revenue $B
4.1
3.9
3.6
3.3
2.9
2.4
2.7
2.5
2.1
2.0
1.8
1.7
1.6
1.4
1.3
1.2
1.1
1.0
Operating income $B
0.7
0.7
0.5
0.5
0.5
0.3
0.5
0.4
0.4
0.3
0.2
0.3
0.3
0.3
0.2
0.2
0.1
0.1
EBITDA $B
1.1
1.1
0.9
0.9
0.8
0.5
0.7
0.5
0.6
0.5
0.4
0.4
0.4
0.4
0.3
0.3
0.2
0.2
Income tax $B
0.2
0.2
0.1
0.1
−2.5
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
0.4
0.4
0.3
0.4
2.9
0.2
0.5
0.1
0.4
0.3
0.2
0.3
0.3
0.2
0.2
0.1
0.1
0.1
EPS, diluted $
1.87
1.96
1.48
1.94
59.16
4.81
9.33
2.81
7.52
5.59
4.14
5.51
5.96
5.05
3.63
2.43
2.21
1.42
Dividend / sh $
·
·
0.01
0.01
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
·
·
·
·
Payout %
0
0
1
1
0
1
1
2
1
1
1
1
1
1
2
2
3
4
ROE %
4.6
5.0
4.0
5.5
54.7
6.4
13.5
4.3
12.7
10.2
7.8
10.8
12.9
12.0
9.7
7.0
6.8
4.5
Shares out B
0.20
0.20
0.20
0.05
0.05
0.05
·
·
·
·
·
·
·
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
70 of 70
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed